Analystreport

Axovant Gene Therapies Ltd (NASDAQ: AXGT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Axovant Gene Therapies Ltd.  (AXGT) 
Last axovant gene therapies ltd. earnings: 2/10 06:00 am Check Earnings Report